{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:36Z","timestamp":1791895476400,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Netherlands Organization for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VIDI","award":["723.012.102"],"award-info":[{"award-number":["723.012.102"]}]},{"name":"Proteins@Work","award":["184.032.201"],"award-info":[{"award-number":["184.032.201"]}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["NKI 2014-7241"],"award-info":[{"award-number":["NKI 2014-7241"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}]},{"name":"ERC","award":["319661 COMBATCANCER"],"award-info":[{"award-number":["319661 COMBATCANCER"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cell.2019.06.014","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T10:29:54Z","timestamp":1562840994000},"page":"585-599.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":240,"title":["Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold"],"prefix":"10.1016","volume":"178","author":[{"given":"David W.","family":"Vredevoogd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten A.","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Boshuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Stecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beaunelle","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Krijgsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Kenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mezzadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Gomez-Eerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Dagidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Apriamashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nordin","family":"Zandhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils L.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian U.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Altelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Peeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2019.06.014_bib1","first-page":"7.20.1","article-title":"Predicting Functional Effect of Human Missense Mutations Using PolyPhen-2","volume":"76","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.cell.2019.06.014_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T\u00a0cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cell.2019.06.014_bib3","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2019.06.014_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.06.014_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.173.3.647","article-title":"Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes","volume":"173","author":"Barth","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1535-7163.MCT-13-0798","article-title":"Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-\u03baB activation, and is active in patient-derived xenograft models","volume":"13","author":"Benetatos","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cell.2019.06.014_bib8","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-017-02358-7","article-title":"TNF\u03b1 blockade overcomes resistance to anti-PD-1 in experimental melanoma","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.06.014_bib9","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1038\/ncomms14278","article-title":"Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma","volume":"8","author":"Beug","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.06.014_bib10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.aac7557","article-title":"Gene essentiality and synthetic lethality in haploid human cells","volume":"350","author":"Blomen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nm.4472","article-title":"Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF\/MEK inhibitors","volume":"24","author":"Boshuizen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib13","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.4049\/jimmunol.181.7.4918","article-title":"CD8 T\u00a0cells utilize TRAIL to control influenza virus infection","volume":"181","author":"Brincks","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cell.2019.06.014_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.10-170480","article-title":"The role of TRADD in TRAIL-induced apoptosis and signaling","volume":"25","author":"Cao","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.cell.2019.06.014_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.06.014_bib17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2019.06.014_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T\u00a0cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/hgtb.2014.004","article-title":"Manufacture of gene-modified human T-cells with a memory stem\/central memory phenotype","volume":"25","author":"Gomez-Eerland","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.cell.2019.06.014_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","article-title":"TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways","volume":"84","author":"Hsu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41467-017-00608-2","article-title":"Predictors of responses to immune checkpoint blockade in advanced melanoma","volume":"8","author":"Jacquelot","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.06.014_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/pcmr.12220","article-title":"Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032","volume":"27","author":"Jenkins","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cell.2019.06.014_bib28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2019.06.014_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ni.3688","article-title":"Early transcriptional and epigenetic regulation of CD8+ T\u00a0cell differentiation revealed by single-cell RNA sequencing","volume":"18","author":"Kakaradov","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2019.06.014_bib30","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/cdd.2017.94","article-title":"PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF","volume":"24","author":"Kearney","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2019.06.014_bib31","doi-asserted-by":"crossref","first-page":"eaar3451","DOI":"10.1126\/sciimmunol.aar3451","article-title":"Tumor immune evasion arises through loss of TNF sensitivity","volume":"3","author":"Kearney","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2019.06.014_bib32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.febslet.2011.05.034","article-title":"TRADD is critical for resistance to TRAIL-induced cell death through NF-\u03baB activation","volume":"585","author":"Kim","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cell.2019.06.014_bib33","doi-asserted-by":"crossref","first-page":"13533","DOI":"10.1074\/jbc.M808554200","article-title":"MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment","volume":"284","author":"Kurada","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.06.014_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1535-7163.MCT-17-0330","article-title":"Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors","volume":"17","author":"Lam","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cell.2019.06.014_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib36","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2019.06.014_bib38","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1101\/gad.13.19.2514","article-title":"Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis","volume":"13","author":"Lin","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2019.06.014_bib39","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2019.06.014_bib41","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0711122105","article-title":"Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation","volume":"105","author":"Mahoney","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.06.014_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In\u00a0vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.06.014_bib43","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T\u00a0cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.06.014_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.06.014_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acs.jproteome.6b00753","article-title":"Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons","volume":"16","author":"Post","year":"2017","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.cell.2019.06.014_bib48","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib49","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2019.06.014_bib50","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib51","doi-asserted-by":"crossref","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","article-title":"Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance","volume":"9","author":"Roh","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib52","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","article-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2019.06.014_bib53","doi-asserted-by":"crossref","first-page":"13455","DOI":"10.1074\/jbc.M112.435917","article-title":"Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity","volume":"288","author":"Salzmann","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.06.014_bib54","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/onc.2011.567","article-title":"Breaking the \u2018harmony\u2019 of TNF-\u03b1 signaling for cancer treatment","volume":"31","author":"Sasi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2019.06.014_bib55","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1074\/jbc.272.18.12069","article-title":"MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase","volume":"272","author":"Schievella","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.06.014_bib56","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1432-1327.1998.2540439.x","article-title":"Apoptosis signaling by death receptors","volume":"254","author":"Schulze-Osthoff","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cell.2019.06.014_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.06.014_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary Resistance to PD-1 Blockade Mediated by JAK1\/2 Mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2019.06.014_bib60","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1073\/pnas.93.24.13973","article-title":"The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex","volume":"93","author":"Shu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.06.014_bib61","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib62","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.06.014_bib63","series-title":"Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research","first-page":"133","author":"Tyanova","year":"2018"},{"key":"10.1016\/j.cell.2019.06.014_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.200801010","article-title":"TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha","volume":"182","author":"Vince","year":"2008","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2019.06.014_bib65","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib66","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.aac7041","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.06.014_bib67","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib68","series-title":"Advances in Protein Chemistry","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0065-3233(04)68007-7","article-title":"Assembly of Post-Receptor Signaling Complexes for the Tumor Necrosis Factor Receptor Superfamily","author":"Wu","year":"2004"},{"key":"10.1016\/j.cell.2019.06.014_bib69","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)80391-X","article-title":"Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice","volume":"7","author":"Yeh","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2019.06.014_bib70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nprot.2010.43","article-title":"Detection of Mycoplasma in cell cultures","volume":"5","author":"Young","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2019.06.014_bib71","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1158\/1078-0432.CCR-06-1805","article-title":"Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b","volume":"13","author":"Yurkovetsky","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2019.06.014_bib72","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.06.014_bib73","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/cmi.2015.57","article-title":"Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment","volume":"12","author":"Zhang","year":"2015","journal-title":"Cell. Mol. Immunol."}],"updated-by":[{"DOI":"10.1016\/j.cell.2020.01.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000}}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867419306774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867419306774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:38:48Z","timestamp":1758800328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867419306774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0092867419306774"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2019.06.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.cell.2020.01.005","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2019.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}